Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Levity vs NowPatient

By GLP-1 ScorecardUpdated

Levity
Site position #406

Lower grade

NowPatient
Site position #243

Higher grade

Score comparison

NowPatient has the higher recorded score — 65.5/100 to 58.8/100.

NowPatient grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NowPatient is a US-UK telehealth platform offering brand-name GLP-1 weight management access including Mounjaro, Wegovy (injection and oral tablet), and Saxenda.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueNowPatient +4
31
35
Dose & formulationNowPatient +8
85
93
Clinical oversightNowPatient +31
55
86
Labs & monitoringLevity +10
64
54
FulfillmentLevity +7
77
70
Contract termsNowPatient +2
53
55
Levity · top barNowPatient · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricLevityNowPatient
WeighScore58.8/10065.5/100
GradeCC
Site position#406#243
Semaglutide$1,199/mo (all doses, bundle, brand-name)$1,349/mo (brand Wegovy)
Tirzepatide$1,299/mo (all doses, bundle, brand-name)$1,069/mo (brand Mounjaro, promotional rate)
Coverage36 statesCoverage not published
Brand-name accessYesYes
Oral / sublingualNot confirmedYes
Levity

Site position #406 · C

FDAWarning letter issued to Levity Inc. dba Levity in February 2026. See the FDA warning-letter database.

Strengths

  • FDA-approved branded Mounjaro, Wegovy, and Ozempic only
  • All-inclusive fee covers Rx, consult, shipping, and support
  • LegitScript verified with named pharmacy and physician leads
  • Available across 34 states with unlimited clinical support

What to consider

  • Premium pricing, roughly 1,199 to 1,599 per month
  • No compounded lower-cost alternatives
  • Support hours limited to weekday business hours
  • Bundled fee may exceed insurance-covered branded options
  • FDA issued Levity Inc. dba Levity a warning letter in February 2026; the letter is public in FDA's warning-letter database
NowPatient

Site position #243 · C

Strengths

  • Free telehealth consultation — you only pay for the medication
  • Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
  • One of the few platforms offering Wegovy in both injection and oral pill form
  • No compounded options — every drug is FDA-approved brand-name

What to consider

  • Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)
  • No compounded semaglutide or tirzepatide (usually the cheaper route)
  • State availability determined during intake, not shown upfront
  • Does not offer Foundayo (orforglipron)

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard